12/19/2024 8:00 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 3:01 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form S-1/A | |
12/11/2024 3:20 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/11/2024 5:01 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
12/10/2024 3:45 PM | LANGER DENNIS (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:46 PM | Leong Natalie Ee Mun (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:47 PM | Myers Michael (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/10/2024 3:47 PM | Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer) SEMBER MICHAEL T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:49 PM | Carter Denise P. (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:50 PM | Culverwell Anthony James (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:51 PM | Dunn Gordon (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:52 PM | Cooper Joseph Patrick (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:23 PM | Lind Global Fund II LP (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024 4:04 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
10/31/2024 3:30 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form ARS | |
10/24/2024 5:15 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form DEF 14A | |
10/11/2024 3:56 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024 5:07 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 3:30 PM | Dunn Gordon (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 11:03 AM | Myers Michael (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 11:06 AM | Carter Denise P. (Reporting) Quoin Pharmaceuticals, Ltd. (Issuer) Quoin Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:32 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B3 | |
06/07/2024 11:24 AM | LANGER DENNIS (Reporting) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
04/02/2024 10:04 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024 3:11 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form POS AM | |
03/14/2024 3:42 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/13/2024 3:52 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 4:07 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form 424B4 | |
02/27/2024 5:01 AM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form DEF 14A | |
02/14/2024 11:15 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form EFFECT | |
02/13/2024 7:11 PM | Lind Global Fund II LP (Filed by) Quoin Pharmaceuticals, Ltd. (Subject) Quoin Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 4:12 PM | Quoin Pharmaceuticals, Ltd. (Filer) Quoin Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |